Skip to main
CI
CI logo

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 34 analyst ratings
Buy
Strong Buy 32%
Buy 47%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is experiencing a positive financial trajectory, highlighted by a 7% year-over-year increase in modified CY25 pre-tax adjusted operating income, reflecting the strength of its core pharmacy benefit management and specialty pharmacy services. Additionally, the company has secured significant client contracts, including a multiyear agreement with Centene and a long-term contract with the Department of Defense, contributing to strong revenue growth. Furthermore, Cigna's Stop-Loss MLR is projected to improve significantly, indicating enhanced profitability and effective pricing strategies aimed at optimizing performance in the competitive health insurance market.

Bears say

Cigna Group's stock outlook is negatively impacted by a significant 4Q24 earnings miss, with adjusted EPS reported at $6.64, which is 15% below consensus estimates and reflects a 2.2% year-over-year decline. The company's total medical enrollment decreased by 3.2% year-over-year, resulting in approximately 633,000 fewer lives covered, further indicating challenges within the Individual and Family Plans segment. Additionally, concerns regarding elevated high-cost claimants in Stop-Loss insurance and declining membership trends raise further doubts about the company's profitability and growth prospects moving forward.

Cigna (CI) has been analyzed by 34 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 47% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 34 analysts, Cigna (CI) has a Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $316.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $316.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.